The Use of Brodalumab in Three Patients with Psoriasis and Psychiatric Comorbidities.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Works matching AU Litchman, Graham H.
Results: 6
1
2
Expert Consensus on the Use of Prognostic Gene Expression Profiling Tests for the Management of Cutaneous Melanoma: Consensus from the Skin Cancer Prevention Working Group.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 4, p. 807, doi. 10.1007/s13555-022-00709-x
- By:
- Publication type:
- Article
3
Impact of a prognostic 40-gene expression profiling test on clinical management decisions for high-risk cutaneous squamous cell carcinoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
4
Usage and perceptions of teledermatology in 2021: a survey of dermatologists.
- Published in:
- International Journal of Dermatology, 2022, v. 61, n. 7, p. e235, doi. 10.1111/ijd.16209
- By:
- Publication type:
- Article
5
Nonhealing hyperkeratotic plaques in a lung cancer patient: what caused it?
- Published in:
- International Journal of Dermatology, 2021, v. 60, n. 8, p. e291, doi. 10.1111/ijd.15325
- By:
- Publication type:
- Article
6
Real-World Evidence Shows Clinicians Appropriately Use the Prognostic 40-Gene Expression Profile (40-GEP) Test for High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients.
- Published in:
- Cancer Investigation, 2022, v. 40, n. 10, p. 911, doi. 10.1080/07357907.2022.2116454
- By:
- Publication type:
- Article